Caszyme is honored to be recognized as a Company to Watch in Gene Editing by Clarivate!
Clarivate spotlights the leading innovators shaping the future of the gene editing field. The recent report highlights Caszyme’s contributions to advancing CRISPR technology and outlines the key stand-out strengths:
- 15+ years of expertise in CRISPR
- Dynamic platform featuring 80+ Cas9 orthologs & Cas12l nucleases
- Applications spanning therapeutics, diagnostics, agriculture & beyond
- Strong global partnerships across diverse industries
- State-of-the-art facilities driving innovation
Read the full report here: https://clarivate.com/life-sciences-healthcare/lp/companies-to-watch-next-generation-gene-editing/